%D8%B3%D9%8A%D8%B3%D8%A7%D8%A8%D8%B1%D9%8A%D8%AF%D8%B3%DB%8C%D8%B2%D8%A7%D9%BE%D8%B1%D8%A7%DB%8C%D8%AFCategory:CisaprideCisapridCisapridCisaprideCisaprida%D8%B3%DB%8C%D8%B2%D8%A7%D9%BE%D8%B1%D8%A7%DB%8C%D8%AFCisapridKisapridaCisaprideCyzaprydCisapridaCisapridCisaprid%D0%A6%D0%B8%D0%B7%D0%B0%D0%BF%D1%80%D0%B8%D0%B4CisaprideQ425295
about
sameAs
probucolclarithromycinpimozideazithromycindroperidol(RS)-methadoneerythromycinhaloperidoldofetilideibutilidechlorpromazineanagrelidedronedarone(RS)-citalopramondansetronamiodaronequinidinesotalolcocainepentamidineprocainamideterfenadinesevofluraneflecainidesulpiridechloroquineastemizoleescitalopramdomperidonemoxifloxacindisopyramidebepridilthioridazinemesoridazinearsenic trioxideHalofantrinesparfloxacin
P769
A multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonists.Novel benzamides as selective and potent gastric prokinetic agents. 1. Synthesis and structure-activity relationships of N-[(2-morpholinyl)alkyl]benzamides.Novel benzamides as selective and potent gastrokinetic agents. 2. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2- morpholinyl]methyl] benzamide citrate (AS-4370) and related compounds.QSAR model for drug human oral bioavailability.Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockersGRIND-based 3D-QSAR and CoMFA to investigate topics dominated by hydrophobic interactions: The case of hERG K+ channel blockers
P921
Q10354103-B9E56321-0CED-4C08-BED5-7897E84FF9A7Q118551-97B870AE-FF12-49DF-8B41-739FC0855682Q144085-A020E2C2-4A41-47DC-B405-F5A8D175914DQ165399-A9E1E871-C9A9-4A9B-9ED5-55AA9E502115Q174259-19E035EB-CA1A-4A64-8BBC-05B7E16E4EF7Q179996-0874A97C-58B3-419A-965E-FC62F8AC9861Q213511-8EA91A2E-FBC8-41DC-B4CA-7855A6A0A42DQ251347-502DB8D5-26ED-4180-8DF3-A37CF6C04729Q3712521-005CA202-C4E8-483D-A94A-A01E562AC1B3Q3791612-7C84DD74-3BED-4F54-B080-87C855396255Q407972-DB8BE593-3D6B-4BF3-A627-A488A05C5877Q408163-8AC0EB4A-E878-43F1-9ED7-4E4A2D5F3742Q408637-C31DCF64-391D-4B14-AB07-64D8165492F3Q409672-613E3FE7-9282-4441-A9D8-FB8859B2DF3FQ410011-D9EAE18C-0072-4ABE-B90C-954BA75CA814Q410061-187531F7-9883-4CD1-9CE9-5A7F7198F230Q412496-872129D3-5EEA-4404-9721-239EC81B556FQ413591-E490EE54-3C2A-4902-8077-D2B632E2B153Q41576-DFE3CF3C-1DD7-46F7-B4C1-E53C2AB64093Q416206-5C9EE4B8-D305-45C8-A662-7E43B7E343AEQ417597-CAAD64B7-C6CA-4B40-A5C5-419D4BAF7DDEQ417909-461F2775-9D97-49B6-A166-BF27C4E4DD62Q419394-EBAAF2A4-DB20-4CD5-8351-9925F85B981FQ421381-2DE68802-18F2-4E26-8CF4-BD96FC6B0084Q422418-B89C95A7-554F-4A49-ADE7-11824F77CF82Q422438-2C67B00F-38A2-4E29-9F75-5E7837269FD2Q423437-DAF43679-CC61-4C05-9FFA-1FD592C89118Q423757-D12E915C-34A3-487F-92AC-7066B4DF0E1BQ424238-CF4BC3AC-CA21-4D36-B0E9-960D98FB5098Q424940-90CAE163-AA59-42D3-B67F-5E537B9548B8Q425120-AB4456FA-54DA-4B90-81D9-BF9D5911D7BAQ4890934-AFE8BC7D-D492-486F-BAB5-E892E628E351Q58375-5367C609-3819-4736-A0E4-04F8005E0E43Q6821618-45EB059B-69E0-4B5B-A32C-7D5C3A5BDBF4Q7739-FF78CF99-53B9-4C26-9BE5-FD510EB70EC5Q947595-75FFC966-6665-4396-A0B8-9BA881AB171AQ976559-7A8A6CFE-636F-4C50-A505-DA925779A52E
P769
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Cisaprid
@de
Cisaprid
@hr
Cisaprid
@sh
Cisaprid
@sr-el
Cisaprida
@es
Cisapride
@it
Cisapride
@nl
Cisapride
@vi
Kisaprida
@id
cisaprid
@cy
type
label
Cisaprid
@de
Cisaprid
@hr
Cisaprid
@sh
Cisaprid
@sr-el
Cisaprida
@es
Cisapride
@it
Cisapride
@nl
Cisapride
@vi
Kisaprida
@id
cisaprid
@cy
altLabel
(+)-(R)-Cisapride
@cy
(+)-(R)-Cisapride
@en
(+-)-Cisapride
@en
4-Amino-5-chloro-N-{1-[3-(4-fl ...... idin-4-yl}-2-methoxy-benzamide
@cy
4-Amino-5-chloro-N-{1-[3-(4-fl ...... idin-4-yl}-2-methoxy-benzamide
@en
4-amino-5-chloro-N-(1-(3-(4-Fl ...... ridin-4-yl)-2-methoxybenzamide
@cy
4-amino-5-chloro-N-(1-(3-(4-Fl ...... ridin-4-yl)-2-methoxybenzamide
@en
C23H29Cl1F1N3O4
@it
C23H29ClFN3O4
@sr
Cisaprid
@cy
prefLabel
Cisaprid
@de
Cisaprid
@hr
Cisaprid
@sh
Cisaprid
@sr-el
Cisaprida
@es
Cisapride
@it
Cisapride
@nl
Cisapride
@vi
Kisaprida
@id
cisaprid
@cy
P2175
P2868
P769
P486
P592
P6366
P646
P661
P662
P683
P2017
CO[C@H]1CN(CC[C@H]1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F
P2067
465.183062
P2115
N0000148339